Schedule 13G ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: 2018-01-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-18-000339
Form type
SC 13G
Filer
Broadfin Capital, LLC
CIK
CIK 1511901
Filed
Jan 11, 2018
Reporting period
Jan 09, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub